Knights Of Columbus Asset Advisors LLC Biogen Inc. Transaction History

Knights Of Columbus Asset Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$222.59 - $267.94 $623,252 - $750,232	2,800 Added 97.9%	5,660 $1.46 Million
Q3 2023 Nov 01, 2023	BUY	$253.3 - $285.89 $724,438 - $817,645	2,860 New	2,860 $735,000
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $588,966 - $943,050	-2,274 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $17,978 - $21,062	74 Added 3.36%	2,274 $636,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $1.9 Million - $2.86 Million	-8,029 Reduced 78.49%	2,200 $539,000
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $564,489 - $651,773	2,132 Added 26.33%	10,229 $2.9 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $2 Million - $2.54 Million	7,437 Added 1126.82%	8,097 $2.56 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $810,701 - $1.12 Million	-3,684 Reduced 84.81%	660 $196,000
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $944,559 - $1.06 Million	4,344 New	4,344 $1.01 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.